Q1 2026 results - Tuesday, April 28, 2026
Press release: English (PDF 0.3 MB) | Deutsch (PDF 0.3 MB)
Interim financial report (PDF 0.3 MB)
Download the interactive presentation (PDF 5.1 MB)
Download 2026 epidemiology data (PDF 0.7 MB)
| Key figures1 | Q1 2026 (USD m) | Q1 2025 (USD m) | % change (USD/cc) |
|---|---|---|---|
| Net sales | 13,113 | 13,233 | -1 (cc: -5) |
| Operating income | 4,235 | 4,663 | -9 (cc: -11) |
| Net income | 3,156 | 3,609 | -13 (cc: -13) |
| EPS (USD) | 1.65 | 1.83 | -10 (cc: -11) |
| Free cash flow | 3,330 | 3,391 | -2 |
Core | |||
| Operating income | 4,897 | 5,575 | -12 (cc: -14) |
| Net income | 3,794 | 4,482 | -15 (cc: -17) |
| EPS (USD) | 1.99 | 2.28 | -13 (cc: -15) |
- Constant currencies (cc), core results and free cash flow are non-IFRS measures. An explanation of non-IFRS measures can be found on page 32 of the Condensed Interim Financial Report. Unless otherwise noted, all growth rates in this Release refer to same period in prior year.